OREXIGEN THERAPEUTICS INC's ticker is and the CUSIP is 686164AB0. A total of 16 filers reported holding OREXIGEN THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $3,550,000 | -25.6% | 10,000,000 | 0.0% | 0.43% | -29.4% |
| Q3 2017 | $4,769,000 | -5.1% | 10,000,000 | 0.0% | 0.61% | -22.3% |
| Q2 2017 | $5,025,000 | -8.2% | 10,000,000 | 0.0% | 0.78% | -16.2% |
| Q1 2017 | $5,475,000 | +82.5% | 10,000,000 | 0.0% | 0.93% | +54.4% |
| Q4 2016 | $3,000,000 | +13.2% | 10,000,000 | 0.0% | 0.60% | +20.8% |
| Q3 2016 | $2,650,000 | – | 10,000,000 | – | 0.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 10,000,000 | $3,550,000 | 0.43% |
| Telemetry Investments, L.L.C. | 2,500,000 | $875,000 | 0.33% |
| UBS OCONNOR LLC | 7,500,000 | $2,780,000,000 | 0.05% |